ROIV insider transactions

President & Immunovant CEO Venker Eric exercised 200,000 shares at a strike of $3.85, sold $6,054,000 worth of shares (200,000 units at $30.27) and covered exercise/tax liability with 34,483 shares, decreasing direct ownership by 2% to 1,613,063 units (SEC Form 4) (withholding obligation)

CFO Pulik Richard covered exercise/tax liability with 18,962 shares, decreasing direct ownership by 6% to 278,549 units (SEC Form 4) to satisfy withholding tax

SEC Form 4 filed by Venker Eric

SEC Form 4 filed by Pulik Richard

SEC Form 4 filed by Humes Jennifer

SEC Form 4 filed by Oren Ilan

SEC Form 4 filed by Epperly Melissa B,

SEC Form 4 filed by Momtazee James C

SEC Form 4 filed by Gline Matthew

SEC Form 4 filed by Humes Jennifer

SEC Form 4 filed by Torti Frank

SEC Form 4 filed by Gline Matthew

SEC Form 4 filed by Sukhatme Mayukh

SEC Form 4 filed by Fitzgerald Meghan

SEC Form 4 filed by Pulik Richard

SEC Form 4 filed by Humes Jennifer

SEC Form 4 filed by Venker Eric

SEC Form 4 filed by Epperly Melissa B,

CFO Pulik Richard covered exercise/tax liability with 1,000 shares, decreasing direct ownership by 0.42% to 238,413 units (SEC Form 4)

President & Immunovant CEO Venker Eric covered exercise/tax liability with 7,051 shares, decreasing direct ownership by 0.43% to 1,647,546 units (SEC Form 4)

President and Vant Chair Torti Frank exercised 3,000,000 shares at a strike of $3.85 and sold $82,039,460 worth of shares (3,000,000 units at $27.35) (SEC Form 4)

President & Immunovant CEO Venker Eric exercised 200,000 shares at a strike of $3.85 and sold $5,298,000 worth of shares (200,000 units at $26.49) (SEC Form 4)

Director Manchester Keith S sold $32,658,518 worth of shares (1,225,784 units at $26.64) (SEC Form 4)

Director Gold Daniel Allen sold $32,658,518 worth of shares (1,225,784 units at $26.64) (SEC Form 4)

Director by Deputization Qvt Financial Lp sold $32,658,518 worth of shares (1,225,784 units at $26.64) (SEC Form 4)

President & CIO Sukhatme Mayukh exercised 651,558 shares at a strike of $12.68, sold $8,985,003 worth of shares (339,441 units at $26.47) and disposed of $8,261,737 worth of shares (312,117 units at $26.47) (SEC Form 4)

Director Momtazee James C was granted 609 shares and covered exercise/tax liability with 122 shares, increasing direct ownership by 0.45% to 109,030 units (SEC Form 4)

Director Epperly Melissa B, covered exercise/tax liability with 54 shares and was granted 815 shares, increasing direct ownership by 1% to 57,665 units (SEC Form 4)

Director Oren Ilan was granted 1,164 shares and covered exercise/tax liability with 124 shares, increasing direct ownership by 0.88% to 119,428 units (SEC Form 4)

President & Immunovant CEO Venker Eric sold $4,384,000 worth of shares (200,000 units at $21.92) and exercised 200,000 shares at a strike of $3.85 (SEC Form 4)

President & CIO Sukhatme Mayukh disposed of $40,553,632 worth of shares (1,867,367 units at $21.72), exercised 3,198,235 shares at a strike of $12.68 and sold $28,902,500 worth of shares (1,330,868 units at $21.72) (SEC Form 4)

President and Vant Chair Torti Frank was granted 175,380 shares, disposed of $1,458,101 worth of shares (64,891 units at $22.47) and gifted 110,489 shares (SEC Form 4)

President & Immunovant CEO Venker Eric exercised 431,689 shares at a strike of $3.85 and sold $6,179,750 worth of shares (275,000 units at $22.47), increasing direct ownership by 10% to 1,654,597 units (SEC Form 4)

CFO Pulik Richard exercised 260,000 shares at a strike of $3.85 and sold $9,122,307 worth of shares (406,731 units at $22.43), decreasing direct ownership by 38% to 239,413 units (SEC Form 4)

CFO Pulik Richard covered exercise/tax liability with 2,129 shares, decreasing direct ownership by 0.55% to 386,144 units (SEC Form 4)

President & CIO Sukhatme Mayukh exercised 59,513 shares at a strike of $12.68, sold $619,528 worth of shares (26,831 units at $23.09) and disposed of $754,627 worth of shares (32,682 units at $23.09) (SEC Form 4)

Director Gold Daniel Allen sold $39,065,213 worth of shares (1,694,614 units at $23.05) (SEC Form 4)

Director Manchester Keith S sold $39,065,213 worth of shares (1,694,614 units at $23.05) (SEC Form 4)

Director by Deputization Qvt Financial Lp sold $39,065,213 worth of shares (1,694,614 units at $23.05) (SEC Form 4)

CEO Gline Matthew exercised 3,870,659 shares at a strike of $12.16, sold $37,723,200 worth of shares (1,740,000 units at $21.68) and disposed of $46,192,687 worth of shares (2,130,659 units at $21.68) (SEC Form 4)

Large owner Ramaswamy Vivek exercised 7,374,868 shares at a strike of $12.68, sold $67,942,352 worth of shares (3,103,745 units at $21.89) and disposed of $93,486,391 worth of shares (4,271,124 units at $21.89), decreasing direct ownership by 0.00% to 33,653,755 units (SEC Form 4)

President & Immunovant CEO Venker Eric exercised 200,000 shares at a strike of $3.85 and sold $4,170,000 worth of shares (200,000 units at $20.85) (SEC Form 4)

CFO Pulik Richard covered exercise/tax liability with 1,235 shares, decreasing direct ownership by 0.32% to 388,273 units (SEC Form 4)

President & Immunovant CEO Venker Eric covered exercise/tax liability with 7,051 shares, decreasing direct ownership by 0.47% to 1,497,908 units (SEC Form 4)

Director Manchester Keith S sold $26,304,500 worth of shares (1,300,000 units at $20.23) (SEC Form 4)

Director Gold Daniel Allen sold $26,304,500 worth of shares (1,300,000 units at $20.23) (SEC Form 4)

Director by Deputization Qvt Financial Lp sold $26,304,500 worth of shares (1,300,000 units at $20.23) (SEC Form 4)

Large owner Ramaswamy Vivek sold $37,939,112 worth of shares (1,854,603 units at $20.46), decreasing direct ownership by 5% to 33,653,756 units (SEC Form 4)

President & Immunovant CEO Venker Eric exercised 200,000 shares at a strike of $3.85 and sold $4,044,000 worth of shares (200,000 units at $20.22) (SEC Form 4)

Director Oren Ilan was granted 1,507 shares and covered exercise/tax liability with 281 shares, increasing direct ownership by 1% to 118,388 units (SEC Form 4)

Director Momtazee James C covered exercise/tax liability with 158 shares and was granted 789 shares, increasing direct ownership by 0.58% to 108,543 units (SEC Form 4)

Director Epperly Melissa B, was granted 1,056 shares, increasing direct ownership by 2% to 56,904 units (SEC Form 4)

President & Immunovant CEO Venker Eric exercised 851,383 shares at a strike of $15.85 and sold $14,467,502 worth of shares (851,383 units at $16.99) (SEC Form 4)

President & Immunovant CEO Venker Eric exercised 125,667 shares at a strike of $15.85 and sold $2,047,336 worth of shares (125,667 units at $16.29) (SEC Form 4)

President & Immunovant CEO Venker Eric exercised 665,159 shares at a strike of $8.95 and sold $10,781,813 worth of shares (665,159 units at $16.21) (SEC Form 4)

CFO Pulik Richard covered exercise/tax liability with 2,341 shares, decreasing direct ownership by 0.60% to 389,508 units (SEC Form 4)

CFO Pulik Richard covered exercise/tax liability with 2,129 shares, decreasing direct ownership by 0.54% to 391,849 units (SEC Form 4)

President & Immunovant CEO Venker Eric exercised 1,562,374 shares at a strike of $3.85 and sold $25,524,777 worth of shares (1,711,000 units at $14.92), decreasing direct ownership by 9% to 1,504,959 units (SEC Form 4)

CEO Gline Matthew bought $49,957 worth of shares (3,315 units at $15.07), increasing direct ownership by 0.02% to 17,287,081 units (SEC Form 4)

Director Oren Ilan was granted 14,524 shares and disposed of $28,132 worth of shares (2,043 units at $13.77), increasing direct ownership by 12% to 117,162 units (SEC Form 4)